Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia

Matute, María Isabel; Castillo-Laborde, Carla

Publication:
Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia

dc.contributor.author	Matute, María Isabel
dc.contributor.author	Castillo-Laborde, Carla
dc.date.accessioned	2025-01-14T17:09:12Z
dc.date.available	2025-01-14T17:09:12Z
dc.date.issued	2024
dc.description.abstract	Background: Access to medicines is a serious problem globally and in Chile. Despite the creation of coverage policies, part of the population with chronic conditions of high prevalence, still does not have access to the medicines it requires and disease control continues to be low. The objective of the study was to estimate the medication use and effective coverage for diabetes, dyslipidemia and hypertension in Chile, analyzing them according to sociodemographic variables and social determinants of health. Methods: Cross-sectional analytical study with information from the 2016-2017 National Health Survey (sample = 6,233 people aged 15 years or older, expanded = 14,518,969). Descriptive analyses of medication use and effective coverage for hypertension, diabetes and dyslipidemia were carried out, and multivariate logistic regression models were developed to analyze possible associations with variables of interest. Results: 60% of people with hypertension or diabetes use medications and only 27.7% in dyslipidemia. While 54.2% of those with diabetes have their glycemia controlled, in hypertension and dyslipidemia the effective coverage drops to 33.3% and 6.6%, respectively. There are no differences in use by health system, but there are differences in the control of hypertension and diabetes, favoring beneficiaries of the private subsystem. Effective coverage of dyslipidemia and hypertension also increases in those using medications. The drugs coincide with the established protocols, although beneficiaries of the private sector report greater use of innovative drugs. Conclusion: A significant proportion of Chileans with hypertension, diabetes or dyslipidemia still do not use the required medications and do not control their conditions.
dc.description.version	Versión Publicada
dc.identifier.citation	Matute I, Castillo-Laborde C. Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia. PLoS One. 2024 Feb 12;19(2):e0297807. doi: 10.1371/journal.pone.0297807
dc.identifier.doi	https://doi.org/10.1371/journal.pone.0297807
dc.identifier.uri	https://hdl.handle.net/11447/9646
dc.language.iso	en
dc.subject	Diabetes Mellitus* / economics
dc.subject	Diabetes Mellitus* / drug therapy
dc.subject	nsurance Coverage* / statistics & numerical data
dc.subject	Hypertension* / drug therapy
dc.subject	Hypertension* / economics
dc.subject	Prescription Drugs* / therapeutic use
dc.subject	Dyslipidemias* / epidemiology
dc.subject	Dyslipidemias* / drug therapy
dc.subject	Dyslipidemias* / economics
dc.title	Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia
dc.type	Article
dcterms.accessRights	Acceso Abierto
dcterms.source	PloS one
dspace.entity.type	Publication
relation.isAuthorOfPublication	1b570626-ec76-4ab9-8c3f-33fca4fa3de4
relation.isAuthorOfPublication	77a0ad54-bedc-48dd-bc0d-6d6fc521b489
relation.isAuthorOfPublication.latestForDiscovery	1b570626-ec76-4ab9-8c3f-33fca4fa3de4